NEW
YORK, Aug. 5, 2022 /PRNewswire/ -- Jakubowitz
Law announces that a securities fraud class action lawsuit has
commenced on behalf of shareholders of Verrica Pharmaceuticals,
Inc. (NASDAQ: VRCA).
To receive updates on the lawsuit, fill out the
form:
https://claimyourloss.com/securities/verrica-pharmaceuticals-inc-loss-submission-
form/?id=30554&from=4
The lawsuit seeks to recover losses for shareholders who
purchased Verrica between May 28,
2021 and May 24, 2022.
Shareholders interested in acting as a lead plaintiff
representing the class of wronged shareholders have until
August 5, 2022 to petition the
court. Your ability to share in any recovery doesn't require that
you serve as a lead plaintiff.
According to a filed complaint, Verrica Pharmaceuticals, Inc.
issued materially false and/or misleading statements and/or failed
to disclose that: (1) there were manufacturing deficiencies at the
facility where Verrica's contract manufacturer produced a bulk
solution for the Company's lead product candidate, VP-102; (2)
these deficiencies were not remediated when Verrica resubmitted its
New Drug Application for VP-12 for molluscum; (3) the foregoing
presented significant risks to Verrica obtaining regulatory
approval of VP-102 for molluscum; and (4) as a result of the
foregoing, defendants' positive statements about the Company's
business, operations, and prospects were materially misleading
and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/vrca-shareholder-alert-jakubowitz-law-reminds-verrica-shareholders-of-a-lead-plaintiff-deadline-of-august-5-2022-301600814.html
SOURCE Jakubowitz Law